Search research articles
Contact Us
Filters
Showing results (61-70 of 111) with videos related to
Page
of 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
March 24, 2010
HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy
Omar Khan, Susan Fotheringham, Victoria Wood, et al.
Scientific Reports
|
March 13, 2025
Activin A affects colorectal cancer progression and immunomodulation in a stage dependent manner
Mark B Wiley, Jessica Bauer, Valentina Alvarez, et al.
BMC Cancer
|
May 18, 2012
EnROL: a multicentre randomised trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme
Robin H Kennedy, Anne Francis, Susan Dutton, et al.
The American Journal of Pathology
|
September 18, 2010
Roles of tetrahydrobiopterin in promoting tumor angiogenesis
Liye Chen, Xin Zeng, Jihui Wang, et al.
Journal of Surgical Oncology
|
February 16, 2018
The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial
Anouck Huijbers, Gabi W van Pelt, Rachel S Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2013
Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer
Enric Domingo, David N Church, Oliver Sieber, et al.
Cancer Gene Therapy
|
May 29, 2002
Identification of FGF receptor-binding peptides for cancer gene therapy
Fukuto Maruta, Alan L Parker, Kerry D Fisher, et al.
Histopathology
|
June 26, 2021
Stromal composition predicts recurrence of early rectal cancer after local excision
Helen J S Jones, Chris Cunningham, Hanne A Askautrud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2002
Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin
Leonard W Seymour, David R Ferry, David Anderson, et al.
Journal of Drug Targeting
|
May 10, 2007
Bacteriophage biopanning in human tumour biopsies to identify cancer-specific targeting ligands
Fukuto Maruta, Noriyuki Akita, Jun Nakayama, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 111) with videos related to
Sort By:
Page
of 12
Proceedings of the National Academy of Sciences of the United States of America
|
March 24, 2010
HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy
Omar Khan, Susan Fotheringham, Victoria Wood, et al.
Scientific Reports
|
March 13, 2025
Activin A affects colorectal cancer progression and immunomodulation in a stage dependent manner
Mark B Wiley, Jessica Bauer, Valentina Alvarez, et al.
BMC Cancer
|
May 18, 2012
EnROL: a multicentre randomised trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme
Robin H Kennedy, Anne Francis, Susan Dutton, et al.
The American Journal of Pathology
|
September 18, 2010
Roles of tetrahydrobiopterin in promoting tumor angiogenesis
Liye Chen, Xin Zeng, Jihui Wang, et al.
Journal of Surgical Oncology
|
February 16, 2018
The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial
Anouck Huijbers, Gabi W van Pelt, Rachel S Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2013
Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer
Enric Domingo, David N Church, Oliver Sieber, et al.
Cancer Gene Therapy
|
May 29, 2002
Identification of FGF receptor-binding peptides for cancer gene therapy
Fukuto Maruta, Alan L Parker, Kerry D Fisher, et al.
Histopathology
|
June 26, 2021
Stromal composition predicts recurrence of early rectal cancer after local excision
Helen J S Jones, Chris Cunningham, Hanne A Askautrud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2002
Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin
Leonard W Seymour, David R Ferry, David Anderson, et al.
Journal of Drug Targeting
|
May 10, 2007
Bacteriophage biopanning in human tumour biopsies to identify cancer-specific targeting ligands
Fukuto Maruta, Noriyuki Akita, Jun Nakayama, et al.
Page
of 12